Dravet syndrome Trials in Philadelphia, United States
Conditions / Dravet syndrome / Philadelphia, United States
Research into Dravet syndrome spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06149663 | Intermediate-Size Expanded Access Protocol (EAP) for LP352 | AVAILABLE | — |
| NCT04442295 | An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome | COMPLETED | PHASE1/PHASE2 |
| NCT04537832 | Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies | TERMINATED | — |
| NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 |
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | COMPLETED | PHASE3 |
| NCT04462770 | A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome | RECRUITING | PHASE3 |
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | ACTIVE_NOT_RECRUITING | — |
| NCT04740476 | An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02682927 | A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 |
| NCT02823145 | An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 |